0001104659-19-031226.txt : 20190522 0001104659-19-031226.hdr.sgml : 20190522 20190522213759 ACCESSION NUMBER: 0001104659-19-031226 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190522 FILED AS OF DATE: 20190522 DATE AS OF CHANGE: 20190522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SVLSF V, LLC CENTRAL INDEX KEY: 0001644160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38916 FILM NUMBER: 19847789 BUSINESS ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 617-367-8100 MAIL ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SV LIFE SCIENCES FUND V LP CENTRAL INDEX KEY: 0001460732 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38916 FILM NUMBER: 19847790 BUSINESS ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 617-973-2708 MAIL ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SV Life Sciences Fund V (GP), LP CENTRAL INDEX KEY: 0001644146 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38916 FILM NUMBER: 19847791 BUSINESS ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 617-367-8100 MAIL ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SV Life Sciences Fund V Strategic Partners, L.P. CENTRAL INDEX KEY: 0001482194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38916 FILM NUMBER: 19847792 BUSINESS ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 617-973-2708 MAIL ADDRESS: STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC STREET 2: ONE BOSTON PLACE, SUITE 3900 CITY: BOSTON STATE: MA ZIP: 02108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS Ltd CENTRAL INDEX KEY: 0001761612 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT BUSINESS PHONE: 011441223261503 MAIL ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT 3 1 a3.xml 3 X0206 3 2019-05-22 0 0001761612 BICYCLE THERAPEUTICS Ltd BCYC 0001644160 SVLSF V, LLC C/O BICYCLE THERAPEUTICS PLC B900, BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT UNITED KINGDOM 0 0 1 0 0001460732 SV LIFE SCIENCES FUND V LP C/O BICYCLE THERAPEUTICS PLC B900, BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT UNITED KINGDOM 0 0 1 0 0001644146 SV Life Sciences Fund V (GP), LP C/O BICYCLE THERAPEUTICS PLC B900, BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT UNITED KINGDOM 0 0 1 0 0001482194 SV Life Sciences Fund V Strategic Partners, L.P. C/O BICYCLE THERAPEUTICS PLC B900, BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT UNITED KINGDOM 0 0 1 0 Series A Preferred Shares Ordinary Shares 874709 I By SV Life Sciences Fund V, L.P. Series B1 Preferred Shares Ordinary Shares 623196 I By SV Life Sciences Fund V, L.P. Series A Preferred Shares Ordinary Shares 18485 I By SV Life Sciences Fund V Strategic Partners L.P. Series B1 Preferred Shares Ordinary Shares 13169 I By SV Life Sciences Fund V Strategic Partners L.P. Each share of Series A Preferred and Series B1 Preferred shall automatically convert into Ordinary shares on a one for 1.429 basis immediately prior to the closing of the Issuer's initial public offering of Ordinary Shares and have no expiration date. Share numbers give effect to the bonus shares issued to each holder of ordinary shares on the basis of 1.429 bonus shares for each ordinary share in issue, effective on May 13, 2019, which will be effective for the ordinary shares upon their conversion to ordinary shares upon the closing of the Issuer's initial public offering. The number of shares reflects the conversion of the Series A Preferred Shares and Series B1 Preferred Shares to Ordinary Shares set out in footnote (1) above. These shares are owned directly by SV Life Sciences Fund V, L.P. ("SVLS V LP"). SV Life Sciences Fund V (GP), LP ("SVLS V GP") is the general partner of SVLS V LP. The general partner of SVLS V GP is SVLSF V, LLC. Kate Bingham, Eugene D. Hill, III and Michael J. Ross are members of the investment committee of SVLSF V, LLC. SVLS V GP, SVLSF V, LLC and each of the individuals comprising the SVLSF V, LLC investment committee may be deemed to share voting, dispositive and investment power over the shares held of record by SVLS V LP. Each of SVLS V GP, SVLSF V, LLC and the individual members of the SVLSF V, LLC investment committee disclaims beneficial ownership of these securities and this report shall not be deemed to be an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or any other purpose, except to the extent of their pecuniary interest therein. These shares are owned directly by SV Life Sciences Fund V Strategic Partners L.P. ("SVLS V SPP"). SVLS V GP is the general partner of SVLS V SPP. The general partner of SVLS V GP is SVLSF V, LLC. Kate Bingham, Eugene D. Hill, III and Michael J. Ross are members of the investment committee of SVLSF V, LLC. SVLS V GP, SVLSF V, LLC and each of the individuals comprising the SVLSF V, LLC investment committee may be deemed to share voting, dispositive and investment power over the shares held of record by SVLS V SPP. Each of SVLS V GP, SVLSF V, LLC and the individual members of the SVLSF V, LLC investment committee disclaims beneficial ownership of these securities and this report shall not be deemed to be an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or any other purpose, except to the extent of their pecuniary interest therein SVLSF V, LLC By: /s/ Brent M. Faduski Name:Brent M. Faduski Title:Officer 2019-05-22 SV LIFE SCIENCES FUND V, L.P. By: /s/ Brent M. Faduski Name:Brent M. Faduski Title:SVLSF V, LLC Officer 2019-05-22 SV LIFE SCIENCES FUND V (GP), L.P. By: /s/ Brent M. Faduski Name:Brent M. Faduski Title:SVLSF V, LLC Officer 2019-05-22 SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P. By: /s/ Brent M. Faduski Name:Brent M. Faduski Title:SVLSF V, LLC Officer 2019-05-22